3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
39
Stomach Neoplasms
29
Rectal Neoplasms
21
Pancreatic Neoplasms
19
Colonic Neoplasms
17
Lymphoma, Large B-Cell, Diffuse
14
Esophageal Neoplasms
13
Adenocarcinoma Of Esophagus
12
Carcinoma, Non-Small-Cell Lung
11
Neoplasms
9
Neoplasm Metastasis
9
Adenocarcinoma
9
Cholangiocarcinoma
8
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Ovarian Neoplasms
6
Biliary Tract Neoplasms
6
Esophageal Squamous Cell Carcinoma
4
Endometrial Neoplasms
4
Carcinoma, Hepatocellular
4
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Lung Neoplasms
3
Gastrointestinal Neoplasms
3
Gallbladder Neoplasms
3
Carcinoma
3
Bile Duct Neoplasms
3
Advanced Solid Tumors
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Spinocerebellar Degenerations
2
Interventions
Cisplatin
6
Platinum
5
Pemetrexed
5
1,2-diaminocyclohexaneplatinum II citrate
5
pembrolizumab
4
atezolizumab
2
Radiotherapy
2
Radiation
2
Nivolumab
2
Ipilimumab
2
Gemcitabine
2
Cyclophosphamide
2
Carboplatin
2
tremelimumab
1
methoxyamine
1
fludarabine
1
decitabine and cedazuridine drug combination
1
cediranib
1
anetumab ravtansine
1
aldesleukin
1
Trioxsalen
1
Tissue Banks
1
Radiotherapy, Intensity-Modulated
1
Proton Therapy
1
Phototherapy
1
Photochemotherapy
1
Pharmacogenomic Testing
1
Pharmaceutical Preparations
1
Interleukin-2
1
Influenza Vaccines
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Oxaliplatin
×
90 days
×
Clear all
No trials found.